Early adversity in chronic depression: clinical correlates and response to pharmacotherapy

Depress Anxiety. 2009;26(8):701-10. doi: 10.1002/da.20577.

Abstract

Background: There is growing evidence suggesting that early adversity may be a marker for a distinct pathway to major depressive disorder (MDD). We examined associations between childhood adversity and a broad variety of clinical characteristics and response to pharmacotherapy in a large sample of patients with chronic forms of MDD.

Methods: Subjects included 808 patients with chronic forms of MDD (chronic MDD, double depression, or recurrent MDD with incomplete recovery between episodes and a total continuous duration of >2 years) who were enrolled in a 12-week open-label trial of algorithm-guided pharmacotherapy. Baseline assessments included a semi-structured diagnostic interview, and clinician- and self-rated measures of depressive symptoms, social functioning, depressotypic cognitions, and personality traits, and childhood adversity. Patients were re-evaluated every 2 weeks.

Results: A longer duration of illness; earlier onset; greater number of episodes, symptom severity, self-rated functional impairment, suicidality, and comorbid anxiety disorder; and higher levels of dysfunctional attitudes and self-criticism were each associated with multiple forms of childhood adversity. A history of maternal overcontrol, paternal abuse, paternal indifference, sexual abuse, and an index of clinically significant abuse each predicted a lower probability of remission. Among patients completing the 12-week trial, 32% with a history of clinically significant abuse, compared to 44% without such a history, achieved remission.

Conclusions: These findings indicate that a history of childhood adversity is associated with an especially chronic form of MDD that is less responsive to antidepressant pharmacotherapy.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Algorithms
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use*
  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / drug therapy
  • Anxiety Disorders / psychology
  • Bupropion / adverse effects
  • Bupropion / therapeutic use
  • Child
  • Child Abuse, Sexual / diagnosis
  • Child Abuse, Sexual / psychology
  • Chronic Disease
  • Citalopram / adverse effects
  • Citalopram / therapeutic use
  • Comorbidity
  • Cyclohexanols / adverse effects
  • Cyclohexanols / therapeutic use
  • Delayed-Action Preparations
  • Depressive Disorder, Major / diagnosis*
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / psychology
  • Female
  • Humans
  • Life Change Events*
  • Male
  • Mianserin / adverse effects
  • Mianserin / analogs & derivatives
  • Mianserin / therapeutic use
  • Middle Aged
  • Mirtazapine
  • Parenting / psychology
  • Risk Factors
  • Self Concept
  • Sertraline / adverse effects
  • Sertraline / therapeutic use
  • Treatment Outcome
  • Venlafaxine Hydrochloride
  • Young Adult

Substances

  • Antidepressive Agents
  • Cyclohexanols
  • Delayed-Action Preparations
  • Bupropion
  • Citalopram
  • Mianserin
  • Venlafaxine Hydrochloride
  • Mirtazapine
  • Sertraline